Display Single Record

FOI Request

Disclosure ID
FOI/03442
Request Date
November 28, 2019
Subject
(VKA) Dosing/VTE Risk Assessment Practice
Description

1). Does your Trust have an Anticoagulant Service for

a) In-patients and out-patients YES / NO

b) In-patients only YES / NO

c) Outpatient only YES / NO

2). How many inpatient beds does your Trust have (at each site if more than 1 site)?

a) How many sites do you inpatient dose (if applicable)?

3). Who doses VKA for your inpatient population?

  1. a) Doctors
  2. b) Advanced nurse practitioners
  3. c) Biomedical Scientists
  4. d) Clinical Nurse Specialists – if so are they nurse prescribers?
  5. e) Pharmacists – If so are they prescribers?
  6. f) Other – free text box

4). How many individuals who are not doctors perform this role in the groups specified above.

5). If you dose warfarin for out-patients, how many warfarin patients do you currently dose?

6). Which dosing software do you use – free text

7). Does your Trust run nurse led Anticoagulation clinics?

YES / NO

8). If there are no nurse led clinics, who is responsible for management of patients taking VKA within your trust.

9). Who completes your VTE Risk assessments?

a) Ward doctors

b) Nurses

c) Pharmacists

d) ANP

e) Other – Please specify

10). What is your current VTE Risk assessment compliance rate?

Response

1). c) Outpatient only.

2). Blackpool Victoria – circa 800

Clifton Hospital – 96

Both

3). a) Doctors

b) & d) both would be non-medical prescribers

4). This data is not readily available, and would be a disproportionate effort to retrieve which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).

5). 4950

6). Dawn Clinical Software

7). No

8). Anticoagulation Practitioners

BMS / Nurse (none at present)

9). a) and/or d)

10). https://improvement.nhs.uk/resources/vte-risk-assessment-q1-201920/

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
Attachment 6
Attachment 7
Attachment 8
Attachment 9